Maximum percentage reduction in tumor size. Data are presented for patients in the all-treated population who had a baseline and at least 1 postbaseline tumor assessment. The number next to each bar indicates the dose cohort (ie, lenalidomide dose) for that patient. // indicates values greater than 100% (112%, 153%, and 414%). SPD, sum of the product of the diameters.